Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
opioids
opioids
Finance
Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By
Geoff Mulvihill
and
The Associated Press
March 19, 2025
Politics
How do Mexico, Canada, and China affect fentanyl flowing into the U.S.?
By
The Associated Press
and
Jesse Bedayn
February 4, 2025
Health
Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By
Geoff Mulvihill
and
The Associated Press
January 24, 2025
Health
Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
By
Julie Carr Smyth
and
The Associated Press
December 11, 2024
Health
Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
By
Andrew DeMillo
and
The Associated Press
June 25, 2024
Health
California partners with pharma firm on generic Narcan amid opioid crisis
By
Adam Beam
and
The Associated Press
April 29, 2024
Health
OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
By
Geoff Mulvihill
and
The Associated Press
February 2, 2024
Health
EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
By
Lindsay Whitehurst
and
The Associated Press
February 1, 2024
Finance
OxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
By
Mark Sherman
and
The Associated Press
December 4, 2023
Health
White patients are more likely than Black patients to be prescribed opioids for pain in US emergency departments. Here’s why it matters
By
Trevor Thompson
,
Sofia Stathi
and
The Conversation
October 29, 2023
Retail
Rite Aid’s years of red ink and opioid losses prompt pharmacy giant to file for bankruptcy
By
Tom Murphy
,
Elaine Kurtenbach
and
The Associated Press
October 17, 2023
Health
The opioid crisis is so bad that prosecutors are starting to charge drug addict parents with their kids’ Fentanyl overdoses
By
Olga R. Rodriguez
and
The Associated Press
September 8, 2023
Leadership
Biden’s DOJ doesn’t think the Sackler family should get released from opioid liability and the Supreme Court agrees—for now
By
Mark Sherman
and
The Associated Press
August 10, 2023
Features
60% of Americans battling drug or alcohol addictions also have jobs. Here are the professions with the highest rates of substance-use disorder
By
Erika Fry
August 4, 2023
Health
Secret limits to stop ‘suspicious’ Xanax and Adderall orders are forcing some legitimate patients to scramble
By
Ike Swetlitz
and
Bloomberg
April 3, 2023
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
Meta’s 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is ‘vibe coding’ right now
By
Eva Roytburg
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore